Literature DB >> 29428298

The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice.

Juliette Hordeaux1, Qiang Wang1, Nathan Katz1, Elizabeth L Buza1, Peter Bell1, James M Wilson2.   

Abstract

Improved delivery of adeno-associated virus (AAV) vectors to the CNS will greatly enhance their clinical utility. Selection of AAV9 variants in a mouse model led to the isolation of a capsid called PHP.B, which resulted in remarkable transduction of the CNS following intravenous infusion. However, we now show here that this enhanced CNS tropism is restricted to the model in which it was selected, i.e., a Cre transgenic mouse in a C57BL/6J background, and was not found in nonhuman primates or the other commonly used mouse strain BALB/cJ. We also report the potential for serious acute toxicity in NHP after systemic administration of high dose of AAV.
Copyright © 2018 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29428298      PMCID: PMC5911151          DOI: 10.1016/j.ymthe.2018.01.018

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  12 in total

1.  Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons.

Authors:  Sandra Duque; Béatrice Joussemet; Christel Riviere; Thibaut Marais; Laurence Dubreil; Anne-Marie Douar; John Fyfe; Philippe Moullier; Marie-Anne Colle; Martine Barkats
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

2.  The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques.

Authors:  Lili Wang; Roberto Calcedo; Huan Wang; Peter Bell; Rebecca Grant; Luk H Vandenberghe; Julio Sanmiguel; Hiroki Morizono; Mark L Batshaw; James M Wilson
Journal:  Mol Ther       Date:  2009-11-03       Impact factor: 11.454

3.  Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo.

Authors:  Christina A Pacak; Cathryn S Mah; Bijoy D Thattaliyath; Thomas J Conlon; Melissa A Lewis; Denise E Cloutier; Irene Zolotukhin; Alice F Tarantal; Barry J Byrne
Journal:  Circ Res       Date:  2006-07-27       Impact factor: 17.367

4.  Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates.

Authors:  Steven J Gray; Valerie Matagne; Lavanya Bachaboina; Swati Yadav; Sergio R Ojeda; R Jude Samulski
Journal:  Mol Ther       Date:  2011-04-12       Impact factor: 11.454

5.  Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.

Authors:  Yasunori Matsuzaki; Ayumu Konno; Ryuta Mochizuki; Yoichiro Shinohara; Keisuke Nitta; Yukihiro Okada; Hirokazu Hirai
Journal:  Neurosci Lett       Date:  2017-11-24       Impact factor: 3.046

6.  Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids.

Authors:  Lili Wang; Peter Bell; Suryanarayan Somanathan; Qiang Wang; Zhenning He; Hongwei Yu; Deirdre McMenamin; Tamara Goode; Roberto Calcedo; James M Wilson
Journal:  Mol Ther       Date:  2015-09-28       Impact factor: 11.454

7.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.

Authors:  Guang-Ping Gao; Mauricio R Alvira; Lili Wang; Roberto Calcedo; Julie Johnston; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

8.  Clades of Adeno-associated viruses are widely disseminated in human tissues.

Authors:  Guangping Gao; Luk H Vandenberghe; Mauricio R Alvira; You Lu; Roberto Calcedo; Xiangyang Zhou; James M Wilson
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders.

Authors:  Adam K Bevan; Sandra Duque; Kevin D Foust; Pablo R Morales; Lyndsey Braun; Leah Schmelzer; Curtis M Chan; Mary McCrate; Louis G Chicoine; Brian D Coley; Paul N Porensky; Stephen J Kolb; Jerry R Mendell; Arthur H M Burghes; Brian K Kaspar
Journal:  Mol Ther       Date:  2011-08-02       Impact factor: 11.454

10.  Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain.

Authors:  Benjamin E Deverman; Piers L Pravdo; Bryan P Simpson; Sripriya Ravindra Kumar; Ken Y Chan; Abhik Banerjee; Wei-Li Wu; Bin Yang; Nina Huber; Sergiu P Pasca; Viviana Gradinaru
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908

View more
  133 in total

1.  Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.

Authors:  Umut Cagin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

3.  AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.

Authors:  William A Liguore; Jacqueline S Domire; Dana Button; Yun Wang; Brett D Dufour; Sathya Srinivasan; Jodi L McBride
Journal:  Mol Ther       Date:  2019-08-05       Impact factor: 11.454

4.  Poster Viewing Sessions PA00-A01 to PA00-A49.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

Review 5.  An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond.

Authors:  Aditi Korlimarla; Jeong-A Lim; Priya S Kishnani; Baodong Sun
Journal:  Ann Transl Med       Date:  2019-07

6.  Neurotropic Properties of AAV-PHP.B Are Shared among Diverse Inbred Strains of Mice.

Authors:  Yasunori Matsuzaki; Masami Tanaka; Sachiko Hakoda; Tatsuki Masuda; Ryota Miyata; Ayumu Konno; Hirokazu Hirai
Journal:  Mol Ther       Date:  2019-02-28       Impact factor: 11.454

Review 7.  Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.

Authors:  Lars M Ittner; Matthias Klugmann; Yazi D Ke
Journal:  Br J Pharmacol       Date:  2019-04-23       Impact factor: 8.739

8.  AAV Engineering Identifies a Species Barrier That Highlights a Portal to the Brain.

Authors:  Luk H Vandenberghe
Journal:  Mol Ther       Date:  2019-04-16       Impact factor: 11.454

9.  Nonhuman Primate Optogenetics: Current Status and Future Prospects.

Authors:  Ken-Ichi Inoue; Masayuki Matsumoto; Masahiko Takada
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Questions Answered and Unanswered by the First CRISPR Editing Study in a Canine Model of Duchenne Muscular Dystrophy.

Authors:  Nalinda B Wasala; Chady H Hakim; Shi-Jie Chen; N Nora Yang; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2019-02-26       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.